Acetyl Tetrapeptide-5 vs Palmitoyl Hexapeptide-12
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Eyeseryl, Ac-beta-Ala-His-Ser-His
Acetyl tetrapeptide-5 is a short synthetic peptide sold by Lipotec (now Lubrizol) as Eyeseryl, made for eye creams that target under-eye puffiness. The pitch is that it reduces fluid leaking into the tissue under the eyes. It is a cosmetic ingredient, and nearly all of the human data comes from the company that sells it.
Also: Biopeptide EL, Pal-VGVAPG
Palmitoyl hexapeptide-12 is the six-amino-acid sequence VGVAPG, a repeating piece of elastin, with a fatty acid tail attached so it can get into skin. It is sold under the trade name Biopeptide EL and pitched for firmness and elasticity, the bounce-back that fades with age. It is a cosmetic ingredient, not an FDA-approved drug, and nobody has published an independent clinical trial showing it visibly changes skin.
Key Comparison Insights
- Both peptides belong to the Skin & Hair category, suggesting similar primary applications.
Detailed Comparison
| Attribute | Acetyl Tetrapeptide-5 | Palmitoyl Hexapeptide-12 |
|---|---|---|
| Category | Skin & Hair | Skin & Hair |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | The peptide is acetyl-beta-alanine-histidine-serine-histidine. The manufacturer's lab work claims three effects: it reduces vascular permeability (less fluid seeping out of small blood vessels, tested in an endothelial cell model), it inhibits glycation (sugar damage to proteins like collagen), and it has some ACE-inhibiting activity that is linked to fluid balance. All of that is in vitro and company-generated. An important reality check: under-eye bags have several causes, and a lot of them in older adults come from fat pads pushing forward and loose skin, not fluid. A peptide aimed at fluid cannot touch fat-pad bags, so even in the best case it fits morning puffiness better than structural eye bags. | VGVAPG repeats many times in elastin, the protein that lets skin snap back. When elastin breaks down, fragments like this are released, and back in 1984 researchers showed VGVAPG attracts fibroblasts and monocytes in the lab, which is the basis for calling it a matrikine: a matrix fragment that tells repair cells to show up and get to work. The palmitoyl tail makes the peptide fat-friendly enough to cross the outer skin layer. A 2025 ex vivo study added a twist: on human skin samples the peptide reached the epidermis, used the skin's own calcium to form a gel, and helped dried-out, lipid-stripped skin hold water and stay less stiff. That reads more like a barrier and film effect than proof of new elastin being built. |
| Common Dosing | 1% of the Eyeseryl solution in an eye cream Twice daily | About 4% of the ingredient solution in a finished product Once or twice daily |
| Administration | Topical (eye creams, gels, serums) | Topical (serums, creams) |
| Typical Duration | 28-60 days in manufacturer studies; ongoing use to maintain any effect | Manufacturer study ran one month; ongoing use for any maintained effect |
| Best Time to Take | Morning and evening, gently patted under the eyes | Morning and/or evening skincare routine |
Possible Side Effects May vary by individual |
|
|
| Research Summary | We could not find an independent, peer-reviewed clinical trial of acetyl tetrapeptide-5. The evidence is manufacturer data reported in trade publications. Lipotec's best-known study used a 1% Eyeseryl cream on one eye and placebo on the other in male volunteers aged 30 to 65, twice daily for 28 days, and reported about a 30% reduction in under-eye puffiness volume, with most volunteers rating it positively. Another supplier document describes a 60-day study in 20 women using a cream with a very low peptide level, scored from photos by a dermatologist. Other summaries quote different numbers (17% to 21%) from studies we could not trace to an original paper. The studies differ in concentration, sex, length and how puffiness was measured, so they cannot be pooled. Independent ingredient databases rate the evidence as limited for exactly this reason. Bottom line: plausible for mild fluid puffiness, cheap to try in an eye cream, but not a fix for true eye bags and not backed by independent trials. | The best peer-reviewed work is a 2025 paper in ACS Applied Bio Materials (Ligorio and colleagues, with co-authors from Estee Lauder) that tracked the peptide in full-thickness human skin from a single donor. It showed penetration into the stratum corneum and epidermis, gel formation driven by calcium, reduced water loss and drying stress in delipidated skin (roughly comparable to 5 percent glycerol for drying stress), and stronger gels when mixed with collagen. Useful mechanistic data, but small samples and no living people. The appearance claims come from the manufacturer: a one-month, double-blind study in 10 women using 4 percent Biopeptide EL twice daily reported 33 percent better firmness and 20 percent better tone. That study is not in PubMed and is far too small to lean on. A separate 2023 trial of an elastin-like recombinant polypeptide built on the same VGVAPG repeat found improved elasticity after 28 days in 30 women, but that was a different molecule. Honest read: plausible biology, real skin penetration, no independent proof of visible results. |
Frequently Asked Questions: Acetyl Tetrapeptide-5 vs Palmitoyl Hexapeptide-12
What is the difference between Acetyl Tetrapeptide-5 and Palmitoyl Hexapeptide-12?
Acetyl Tetrapeptide-5 is a skin & hair peptide that acetyl tetrapeptide-5 is a short synthetic peptide sold by lipotec (now lubrizol) as eyeseryl, made for eye creams that target under-eye puffiness. the pitch is that it reduces fluid leaking into the tissue under the eyes. it is a cosmetic ingredient, and nearly all of the human data comes from the company that sells it. Palmitoyl Hexapeptide-12 is a skin & hair peptide that palmitoyl hexapeptide-12 is the six-amino-acid sequence vgvapg, a repeating piece of elastin, with a fatty acid tail attached so it can get into skin. it is sold under the trade name biopeptide el and pitched for firmness and elasticity, the bounce-back that fades with age. it is a cosmetic ingredient, not an fda-approved drug, and nobody has published an independent clinical trial showing it visibly changes skin. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Acetyl Tetrapeptide-5 or Palmitoyl Hexapeptide-12?
Neither is universally "better" - the choice depends on your specific goals. Acetyl Tetrapeptide-5 is typically used for skin & hair purposes, while Palmitoyl Hexapeptide-12 is used for skin & hair. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Acetyl Tetrapeptide-5 and Palmitoyl Hexapeptide-12 be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Acetyl Tetrapeptide-5 and Palmitoyl Hexapeptide-12 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.